乳腺癌骨转移相关生物标志物的研究进展
乳腺癌骨转移约占转移性乳腺癌患者的65%至75%,发生转移后5年生存率由90%降至10%。骨放射性核素显像、X线、CT和MRI等影像检查常用于诊断乳腺癌骨转移,而血清生物标志物通常能比影像学更早发现病理变化。本文综述乳腺癌骨转移血清生物标志物的研究进展。
要点
- 乳腺癌骨转移是最常见的远处转移部位,约占转移性乳腺癌患者的65%至75%。
- 无转移的早期乳腺癌5年生存率高达90%,一旦发生转移则降至10%。
- 血清生物标志物通常能比影像学检查更早发现病理变化。
核心结论
- 本文综述乳腺癌骨转移血清生物标志物的研究进展,血清生物标志物通常能比影像学更早检测到病理变化。
研究设计与样本
- 综述,描述乳腺癌骨转移血清生物标志物的研究进展。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Breast cancer is by far the most common malignancy in females. And bone is the most common site of distant metastasis in breast cancer, accounting for about 65 to 75% of all metastatic breast cancer patients.1,2Bone metastasis is an important factor affecting the prognosis of breast cancer. When patients have early-stage breast cancer without metastasis, their 5-year survival rate is as high as 90%, and once metastasis occurs, their 5-year survival rate will drop to 10%.3 Bone radionuclide imaging (ECT), X-ray, CT scan, MRI and other imaging tests to diagnose breast cancer bone metastasis are commonly used in clinical, It is currently believed that breast cancer bone metastasis is a multistep process: first, breast cancer cells need to acquire invasive and metastatic properties; breast cancer cells enter the blood circulation and migrate from blood breast cancer cells enter the blood circulation and migrate from blood vessels to bone tissue in a targeted manner; breast cancer cells adhere and remain in bone tissue and colonise it; and finally, it leads to bone destruction.4 Several key molecules are involved in breast cancer bone metastasis, and serum biomarkers are generally able to detect pathological changes earlier Several key molecules are involved in breast cancer bone metastasis, and serum biomarkers are generally able to detect pathological changes earlier than imaging.5 This review describes the progress of serum biomarkers for breast cancer bone metastasis.
引用
- Xu, Tang. Advances in the study of biomarkers related to bone metastasis in breast cancer. Br J Radiol. 2023. PMID: 37393528. doi:10.1259/bjr.20230117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。